Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Balanced, Single Dose, Three-treatment, Three-period, Crossover Bioavailability Study of Azithromycin Oleogel in Healthy, Adult, Human Subjects Under Fasting Condition.

NCT05796362 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT05796362
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05796362 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Balanced, Single Dose, Three-treatment, Three-period, Crossover Bioavailability Study of Azithromycin Oleogel in Healthy, Adult, Human Subjects Under Fasting Condition.
Lead sponsor
Brigham and Women's Hospital
Phase
Phase 1
Overall status
Completed
Start date
August 8, 2024
Completion date
November 25, 2025
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clinical infection, drug effect, infectious disease